CYP2U1
CYP2U1 (cytochrome P450 family 2 subfamily U member 1, also known as SPG49 and SPG56) is a cytochrome P450 monooxygenase that metabolises arachidonic acid and other long chain fatty acids. It belongs to the cytochrome P450 family 2 gene group. Browse Assay Genie's current range of CYP2U1 research reagents below, or read on for the biology behind the target.
CYP2U1 is a cytochrome P450 monooxygenase involved in the metabolism of arachidonic acid and its conjugates. Mechanistically, it uses molecular oxygen, inserting one oxygen atom into a substrate and reducing the second to water, with two electrons supplied by NADPH through cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase). It acts as an omega and omega-1 hydroxylase for arachidonic acid and possibly for other long chain fatty acids, and it also metabolises docosahexaenoic acid.
Through this activity the enzyme may modulate the arachidonic acid signalling pathway and other fatty acid signalling processes. It may also down-regulate the activity of N-arachidonoyl-serotonin, an endocannabinoid with anti-nociceptive effects that acts by inhibiting fatty acid amide hydrolase (FAAH), the TRPV1 receptor and T-type calcium channels. CYP2U1 catalyses C-2 oxidation of the indole ring of N-arachidonoyl-serotonin, forming the less active product 2-oxo-N-arachidonoyl-serotonin.
The CYP2U1 gene encodes a member of the cytochrome P450 superfamily, whose monooxygenases catalyse many reactions in drug metabolism and in the synthesis of cholesterol, steroids and other lipids. UniProt places the protein in the endoplasmic reticulum membrane, microsome membrane and mitochondrion inner membrane. The gene has been listed under the aliases SPG49 and SPG56, and an earlier HGNC name was spastic paraplegia 56 (autosomal dominant). Mouse and rat both carry a Cyp2u1 ortholog, which is relevant when planning a CYP2U1 antibody or CYP2U1 ELISA kit experiment in rodent models.
CYP2U1 hydroxylates arachidonic acid, docosahexaenoic acid and other long chain fatty acids, making it a useful subject for lipid metabolism studies.
The enzyme may modulate arachidonic acid and other fatty acid signalling processes, so it is studied in lipid mediator biology.
CYP2U1 oxidises N-arachidonoyl-serotonin to a less active product, linking it to endocannabinoid activity involving FAAH, TRPV1 and T-type calcium channels.
As a family 2 P450 using NADPH and cytochrome P450 reductase, CYP2U1 informs work on monooxygenase mechanism and membrane localisation.
CYP2U1 is a cytochrome P450 monooxygenase that acts as an omega and omega-1 hydroxylase for arachidonic acid and possibly other long chain fatty acids. It receives electrons from NADPH via cytochrome P450 reductase and also oxidises the endocannabinoid N-arachidonoyl-serotonin to a less active product.
The HGNC name is cytochrome P450 family 2 subfamily U member 1, and UniProt calls the protein cytochrome P450 2U1. Aliases are SPG49 and SPG56. Earlier names were cytochrome P450, family 2, subfamily U, polypeptide 1, and spastic paraplegia 56 (autosomal dominant).
Yes. Mouse and rat each have an ortholog named Cyp2u1. The human gene is a member of the cytochrome P450 family 2 group. Researchers working in rodents should check the datasheet of any product for its validated reactivity.
Other cytochrome P450 family 2 members and related monooxygenases involved in lipid, steroid and xenobiotic metabolism.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q7Z449; product specifications from Assay Genie datasheets.